902 related articles for article (PubMed ID: 32778778)
1. A compendium of mutational cancer driver genes.
Martínez-Jiménez F; Muiños F; Sentís I; Deu-Pons J; Reyes-Salazar I; Arnedo-Pac C; Mularoni L; Pich O; Bonet J; Kranas H; Gonzalez-Perez A; Lopez-Bigas N
Nat Rev Cancer; 2020 Oct; 20(10):555-572. PubMed ID: 32778778
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive identification of mutational cancer driver genes across 12 tumor types.
Tamborero D; Gonzalez-Perez A; Perez-Llamas C; Deu-Pons J; Kandoth C; Reimand J; Lawrence MS; Getz G; Bader GD; Ding L; Lopez-Bigas N
Sci Rep; 2013 Oct; 3():2650. PubMed ID: 24084849
[TBL] [Abstract][Full Text] [Related]
3. Pan-cancer analysis of somatic mutations in miRNA genes.
Urbanek-Trzeciak MO; Galka-Marciniak P; Nawrocka PM; Kowal E; Szwec S; Giefing M; Kozlowski P
EBioMedicine; 2020 Nov; 61():103051. PubMed ID: 33038763
[TBL] [Abstract][Full Text] [Related]
4. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
6. Identification of druggable cancer driver genes amplified across TCGA datasets.
Chen Y; McGee J; Chen X; Doman TN; Gong X; Zhang Y; Hamm N; Ma X; Higgs RE; Bhagwat SV; Buchanan S; Peng SB; Staschke KA; Yadav V; Yue Y; Kouros-Mehr H
PLoS One; 2014; 9(5):e98293. PubMed ID: 24874471
[TBL] [Abstract][Full Text] [Related]
7. Discovery of Cancer Driver Long Noncoding RNAs across 1112 Tumour Genomes: New Candidates and Distinguishing Features.
Lanzós A; Carlevaro-Fita J; Mularoni L; Reverter F; Palumbo E; Guigó R; Johnson R
Sci Rep; 2017 Jan; 7():41544. PubMed ID: 28128360
[TBL] [Abstract][Full Text] [Related]
8. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
[TBL] [Abstract][Full Text] [Related]
9. An integrated analysis of cancer genes in clear cell renal cell carcinoma.
Li J; Guo L; Ai Z
Future Oncol; 2017 Apr; 13(8):715-725. PubMed ID: 28266251
[TBL] [Abstract][Full Text] [Related]
10. RAS mutations in human cancers: Roles in precision medicine.
Murugan AK; Grieco M; Tsuchida N
Semin Cancer Biol; 2019 Dec; 59():23-35. PubMed ID: 31255772
[TBL] [Abstract][Full Text] [Related]
11. Ontology-based prediction of cancer driver genes.
Althubaiti S; Karwath A; Dallol A; Noor A; Alkhayyat SS; Alwassia R; Mineta K; Gojobori T; Beggs AD; Schofield PN; Gkoutos GV; Hoehndorf R
Sci Rep; 2019 Nov; 9(1):17405. PubMed ID: 31757986
[TBL] [Abstract][Full Text] [Related]
12. Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia.
Haider S; McIntyre A; van Stiphout RG; Winchester LM; Wigfield S; Harris AL; Buffa FM
Genome Biol; 2016 Jun; 17(1):140. PubMed ID: 27358048
[TBL] [Abstract][Full Text] [Related]
13. Dynamic changes of driver genes' mutations across clinical stages in nine cancer types.
Li X
Cancer Med; 2016 Jul; 5(7):1556-65. PubMed ID: 26992457
[TBL] [Abstract][Full Text] [Related]
14. Integration of somatic mutation, expression and functional data reveals potential driver genes predictive of breast cancer survival.
Suo C; Hrydziuszko O; Lee D; Pramana S; Saputra D; Joshi H; Calza S; Pawitan Y
Bioinformatics; 2015 Aug; 31(16):2607-13. PubMed ID: 25810432
[TBL] [Abstract][Full Text] [Related]
15. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
16. Rational design of cancer gene panels with OncoPaD.
Rubio-Perez C; Deu-Pons J; Tamborero D; Lopez-Bigas N; Gonzalez-Perez A
Genome Med; 2016 Oct; 8(1):98. PubMed ID: 27716338
[TBL] [Abstract][Full Text] [Related]
17. In silico saturation mutagenesis of cancer genes.
Muiños F; Martínez-Jiménez F; Pich O; Gonzalez-Perez A; Lopez-Bigas N
Nature; 2021 Aug; 596(7872):428-432. PubMed ID: 34321661
[TBL] [Abstract][Full Text] [Related]
18. Cancer driver gene discovery through an integrative genomics approach in a non-parametric Bayesian framework.
Yang H; Wei Q; Zhong X; Yang H; Li B
Bioinformatics; 2017 Feb; 33(4):483-490. PubMed ID: 27797769
[TBL] [Abstract][Full Text] [Related]
19. SB Driver Analysis: a Sleeping Beauty cancer driver analysis framework for identifying and prioritizing experimentally actionable oncogenes and tumor suppressors.
Newberg JY; Black MA; Jenkins NA; Copeland NG; Mann KM; Mann MB
Nucleic Acids Res; 2018 Sep; 46(16):e94. PubMed ID: 29846651
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer assessment of mutational landscape in intrinsically disordered hotspots reveals potential driver genes.
Zou H; Pan T; Gao Y; Chen R; Li S; Guo J; Tian Z; Xu G; Xu J; Ma Y; Li Y
Nucleic Acids Res; 2022 May; 50(9):e49. PubMed ID: 35061901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
